Precision AQ Augments Access Experience Team with Leading Oncology Talent

Precision AQ, a prominent player in life sciences commercialization, is taking significant strides to advance patient access to vital therapies. The firm has recently boosted its Access Experience Team (AET) by bringing on board three distinguished oncology specialists: Shraddha Kansagra, Angelica Norrell, and Courtney Patterson. This strategic expansion underlines Precision AQ’s dedication to optimizing patient access, particularly in the rapidly evolving oncology landscape.

The landscape of oncology access is transforming, driven by an increasingly complex interplay of payer and provider perspectives. The incorporation of these three experts into the AET aims to provide life science companies with critical insights into navigating challenges related to payer issues and access strategies. The AET is now even better equipped to assist clients in optimizing access to innovative oncology therapies, ensuring that patients receive the life-changing treatments they require.

Meet the New Additions

1. Shraddha Kansagra, PharmD, BCOP - As the newly appointed Vice President of Clinical Oncology Solutions, Dr. Kansagra previously worked as a Clinical Pharmacy Specialist at the University of Texas, Southwestern (UTSW). During her tenure there, she made strides in enhancing patient care through quality improvement initiatives and developing treatment protocols for chemotherapy and immunotherapy. Dr. Kansagra holds a PharmD and a Bachelor’s degree in Pharmacy Studies from the University of Connecticut.

2. Angelica Norrell, PharmD, BCOP, CSP - Dr. Norrell joins as a Senior Director of the AET. Before this role, she was the Senior Director of Product - Oncology and Specialty at Optum, where she managed Oncology Utilization Management and supported over 30 million patients across various health plans. She holds a Doctor of Pharmacy degree from the University of Georgia and is recognized for her double board certification in Oncology and Specialty Pharmacy.

3. Courtney Patterson, PharmD, MBA - Appointed as Vice President of Clinical Oncology Solutions, Dr. Patterson has an impressive background, most recently serving as the System Director of Oncology Pharmacy Services at Advocate Health. She earned her PharmD from Florida A&M University and completed her MBA at Loyola University Chicago, solidifying her expertise in the field.

Enhanced Expertise for Improved Patient Access

The addition of these experts greatly enhances Precision AQ's capacity to analyze and predict emerging trends in coverage and reimbursement in the oncology sector. As the healthcare environment becomes more convoluted, the AET's experienced professionals will facilitate smoother navigation of complex oncology access aspects, ensuring clients stay ahead of payer-related changes.

Chad Clark, President and COO of Precision Medicine Group, expressed enthusiasm regarding the new appointments: "We are delighted to welcome Shraddha, Angie, and Courtney to Precision AQ, bolstering our AET with additional expertise in oncology, one of the most innovative areas in healthcare."

About Precision AQ

Precision AQ is a cornerstone of Precision Medicine Group, dedicated to aiding life sciences companies through the intricacies of commercialization. The AET, originally established in 2009, is composed of over 25 former decision-makers from major managed care organizations and specialty pharmacies, providing unparalleled insights into access decision-making. Beyond the AET's expansion, Precision AQ offers a comprehensive range of services such as global pricing strategies, managed markets marketing, and patient insights services, all aimed at ensuring that transformative therapies are accessible to patients who need them.

As Precision AQ continues to strengthen its AET with industry experts, it reaffirms its position as a trusted ally for life sciences companies, adept at navigating the intricate web of healthcare regulations, payer dynamics, and market accessibility.